ctrl K

Price Alert

Nektar Therapeutics (NKTR)

NASDAQ: NKTR · Real-Time Price · USD

27.24

0.55 (2.06%)

At close: Aug 15, 2025, 3:59 PM

26.80

-1.62%

After-hours: Aug 15, 2025, 07:25 PM EDT

Nektar Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	44.25M	35.28M	88.23M	25.22M
Short-Term Investments	210.97M	268.34M	416.75M	708.74M
Long-Term Investments	26.09M	25.82M	n/a	64.83M
Other Long-Term Assets	4.65M	4.64M	2.25M	2.74M
Receivables	1.61M	2.25M	5.98M	22.49M
Inventory	n/a	16.1M	19.2M	15.8M
Other Current Assets	n/a	n/a	2.42M	n/a
Total Current Assets	261.29M	330.7M	545.97M	795.58M
Property-Plant & Equipment	11.82M	36.86M	85.89M	177.53M
Goodwill & Intangibles	n/a	n/a	76.5M	76.5M
Total Long-Term Assets	42.56M	67.33M	164.63M	321.61M
Total Assets	303.85M	398.03M	710.6M	1.12B
Account Payables	11.56M	9.85M	12.98M	9.75M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	19.26M	18.67M	17.44M
Other Current Liabilities	29.97M	-2.65M	8.31M	24.84M
Total Current Liabilities	61.4M	51.27M	68.2M	85.2M
Long-Term Debt	91.78M	112.63M	126.47M	148.11M
Other Long-Term Liabilities	7.24M	4.63M	36.46M	78.63M
Total Long-Term Liabilities	181.71M	215.78M	275.76M	352.48M
Total Liabilities	243.11M	267.05M	343.96M	437.68M
Total Debt	102.56M	117.78M	131.5M	143.18M
Common Stock	19K	19K	19K	19K
Retained Earnings	-3.6B	-3.48B	-3.2B	-2.83B
Comprehensive Income	61K	80K	-6.91M	-4.16M
Shareholders Equity	60.74M	130.99M	366.64M	679.51M
Total Investments	237.06M	294.16M	416.75M	773.57M